Hepatic impairment/alcohol use: Consider 23 g/day ceilings, extend dosing intervals, and monitor LFTs for multi-day use
Patients may also drink an excessive amount of water (2-4 qt) or use diuretics to purposefully dilute their urine and the urine drug concentration to decrease the chance of detection
Larger, randomized controlled trials with extended follow-up periods are needed to establish definitive guidelines for the use of arGLP-1 in post-bariatric care
Because it stimulates powerful growth pathways in the brain, researchers have flagged several risks and the absence of human trials means its long-term effects are unknown
Subsequently, it concludes with additional set of genes (i.e., Kras )
How PlexusDx Supports a More Personalized Approach PlexusDx's biomarker-informed approach recognizes that baseline lab work and genetic predisposition screening help providers optimize your GLP-1 therapy from day one